Biotheus Inc. (CN)

Biotheus is a fast-growing biotechnology company based in Zhuhai, Guangdong, China with expectations to expand to >60 employees by 2019. Biotheus’ management team has broad experience from drug discovery to NDA filing in China. Biotheus is developing a broad me-better/novel target pipeline focused on immuno-oncology and metabolic disease areas, with the aim to develop their leading assets towards market authorization. Biotheus is actively looking for late-stage clinical and commercialization partners to fulfill these aims. *

	Start	2019-08-20 existent
	Industry	BIOTECH
	Industry 2	cancer immunotherapy (immuno-oncology, I-O)

	City	n. a. Zhuhai, Guangdong
		Address record changed: 2019-08-22

Basic data	Employees	C: 51 to 100 (2019-08-20)

		* Document for ï¿½About Sectionï¿½: Alligator Bioscience AB. (8/20/19). "Press Release: Alligator Bioscience Signs Antibody Agreement for Greater China with Biotheus Inc.". Lund.

		Record changed: 2020-03-14

Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

More documents for Biotheus Inc. (CN)

[1] Alligator Bioscience AB. (8/20/19). "Press Release: Alligator Bioscience Signs Antibody Agreement for Greater China with Biotheus Inc.". Lund....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]